Artemis Strategic Investment Corp financial data

Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Location
3310 East Corona Avenue, Phoenix, AZ
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2023 - Aug 10, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 88.6 % +149%
Debt-to-equity -777 %
Return On Equity -58.2 % -82.3%
Return On Assets 1.98 % -14.3%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 200M USD

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -2.23M USD +58.2%
Nonoperating Income (Expense) 8.19M USD -54.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2.2M USD -51.3%
Income Tax Expense (Benefit) 805K USD
Net Income (Loss) Attributable to Parent 4.14M USD +15.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 51.4K USD -89.7%
Assets, Current 189M USD +23778%
Assets 211M USD +2.35%
Liabilities, Current 196M USD +3953%
Liabilities 197M USD +1337%
Retained Earnings (Accumulated Deficit) -6.84M USD +45.8%
Stockholders' Equity Attributable to Parent -6.84M USD +45.8%
Liabilities and Equity 211M USD +2.35%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -258K USD +19.1%
Net Cash Provided by (Used in) Investing Activities 151K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -108K USD +66.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 51.4K USD -89.7%
Deferred Tax Assets, Valuation Allowance 1.32M USD +383%
Deferred Tax Assets, Gross 1.59M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%